Prescription drug · BLA
Proleukin (aldesleukin) NDC 73776-022
Aldesleukin 1.1 mg/mL · Injection, Powder, Lyophilized, For solution · Intravenous · Iovance Biotherapeutics, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73776-022-01 | 73776002201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (73776-022-01) / 1 mL in 1 VIAL, SINGLE-DOSEMarketed from Jul 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Proleukin
- Generic name (nonproprietary)
- aldesleukin
- Active ingredients
- Aldesleukin — 1.1 mg/mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Iovance Biotherapeutics, Inc
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 103293
- Marketing start
- Listing expires
- Other FDA classes
- Increased Lymphocyte Activation (Physiologic effect)Increased Lymphocyte Cell Production (Physiologic effect)Interleukin-2 (Chemical structure)
- Identifiers
- Product ID 73776-022_29ba86b1-f672-482e-e063-6394a90a931fSPL ID 29ba86b1-f672-482e-e063-6394a90a931fSPL set ID f3c516ad-d405-4fbe-af6a-962080dbfa7dRxCUI 105648, 307816UNII M89N0Q7EQR
- Pharmacologic class
- Lymphocyte Growth Factor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N473776002201followed by a unit qualifier and the quantityPackage 73776-0022-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Proleukin is a lymphocyte growth factor indicated for: The treatment of adults with metastatic renal cell carcinoma. ( 1.1 ) The treatment of adults with metastatic melanoma. ( 1.2 ) 1.1 Metastatic Renal Cell Carcinoma Proleukin is indicated for the treatment of adults with metastatic renal cell carcinoma (RCC). 1.2 Metastatic Melanoma Proleukin is indicated for the treatment of adults with metastatic melanoma.
Excerpt only. Read the full label for complete information.